Cargando…

Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome

The aim of this study was to provide a better insight into breast cancer response to chemotherapy. Chemotherapy improves outcome in breast cancer patients. The effect of cytotoxic treatment cannot be predicted for individual patients. Therefore, the identification of tumour characteristics associate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Faneyte, I F, Schrama, J G, Peterse, J L, Remijnse, P L, Rodenhuis, S, van de Vijver, M J
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2003
Materias:	Molecular and Cellular Pathology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747533/ https://www.ncbi.nlm.nih.gov/pubmed/12569384 http://dx.doi.org/10.1038/sj.bjc.6600749

Ejemplares similares

Marker genes for circulating tumour cells predict survival in metastasized breast cancer patients
por: Weigelt, B, et al.
Publicado: (2003)

Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple mRNA markers
por: Weigelt, B, et al.
Publicado: (2004)

Prediction of outcome in locally advanced breast cancer by post-chemotherapy nodal status and baseline serum tumour markers
por: Brenner, B, et al.
Publicado: (2002)

SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer
por: Boulay, J-L, et al.
Publicado: (2002)

The influence of tamoxifen treatment on the oestrogen receptor in metachronous contralateral breast cancer
por: Kaas, R, et al.
Publicado: (2003)

Effect of neoadjuvant treatment with anastrozole on tumour histology in postmenopausal women with large operable breast cancer
por: Anderson, T J, et al.
Publicado: (2002)

DNA topoisomerase IIα expression and the response toprimary chemotherapy in breast cancer
por: MacGrogan, G, et al.
Publicado: (2003)

Inverse relationship between ER-β and SRC-1 predicts outcome in endocrine-resistant breast cancer
por: Myers, E, et al.
Publicado: (2004)

Identifying pre-post chemotherapy differences in gene expression in breast tumours: a statistical method appropriate for this aim
por: Korn, E L, et al.
Publicado: (2002)

Predicting aggressive outcome in T1N0M0 breast cancer
por: Kronqvist, P, et al.
Publicado: (2004)

Early changes in apoptosis and proliferation following primary chemotherapy for breast cancer
por: Archer, C D, et al.
Publicado: (2003)

Tumour microvessel density as predictor of chemotherapy response in breast cancer patients
por: Tynninen, O, et al.
Publicado: (2002)

Infiltrating ductal and lobular breast carcinomas are characterised by different interrelationships among markers related to angiogenesis and hormone dependence
por: Coradini, D, et al.
Publicado: (2002)

Serum markers of matrix turnover as predictors for the evolution of colorectal cancer metastasis under chemotherapy
por: Hanke, B, et al.
Publicado: (2003)

Prostate-Specific Ets (PSE) factor: a novel marker for detection of metastatic breast cancer in axillary lymph nodes
por: Mitas, M, et al.
Publicado: (2002)

Overexpression of P70 S6 kinase protein is associated with increased risk of locoregional recurrence in node-negative premenopausal early breast cancer patients
por: van der Hage, J A, et al.
Publicado: (2004)

Role of biological markers in the clinical outcome of colon cancer
por: Nanni, O, et al.
Publicado: (2002)

Proteomic analysis of nipple aspirate fluid to detect biologic markers of breast cancer
por: Sauter, E R, et al.
Publicado: (2002)

Carbonic anhydrase XII is a marker of good prognosis in invasive breast carcinoma
por: Watson, P H, et al.
Publicado: (2003)

Carbonic anhydrase-9 expression levels and prognosis in human breast cancer: association with treatment outcome
por: Span, P N, et al.
Publicado: (2003)

Higher expression of human kallikrein 10 in breast cancer tissue predicts tamoxifen resistance
por: Luo, L-Y, et al.
Publicado: (2002)

Activation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patients
por: Pérez-Tenorio, G, et al.
Publicado: (2002)

Glomeruloid microvascular proliferation is associated with p53 expression, germline BRCA1 mutations and an adverse outcome following breast cancer
por: Goffin, J R, et al.
Publicado: (2003)

GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON
por: Hoskin, P J, et al.
Publicado: (2003)

p53 as a potential predictive factor of response to chemotherapy: feasibility of p53 assessment using a functional test in yeast from trucut biopsies in breast cancer patients
por: Bonnefoi, H, et al.
Publicado: (2002)

The Ki67 index a prognostic marker in medullary thyroid carcinoma
por: Tisell, L E, et al.
Publicado: (2003)

Fibroblast growth factor 8 is expressed at higher levels in lactating human breast and in breast cancer
por: Zammit, C, et al.
Publicado: (2002)

Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis
por: Wang, W, et al.
Publicado: (2004)

Prognostic factors for patients with hepatic metastases from breast cancer
por: Wyld, L, et al.
Publicado: (2003)

The association of breast mitogens with mammographic densities
por: Boyd, N F, et al.
Publicado: (2002)

The parathyroid hormone-related protein receptor is expressed in breast cancer bone metastases and promotes autocrine proliferation in breast carcinoma cells
por: Hoey, R P, et al.
Publicado: (2003)

Lung resistance-related protein as a predictor of clinical outcome in advanced testicular germ-cell tumours
por: Zurita, A J, et al.
Publicado: (2003)

The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancer
por: Yousef, G M, et al.
Publicado: (2002)

Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients
por: Stendahl, M, et al.
Publicado: (2004)

Bone metastases from breast carcinoma: histopathological – radiological correlations and prognostic features
por: James, J J, et al.
Publicado: (2003)

Prediction of metastasis risk (11 year follow-up) using VEGF-R1, VEGF-R2, Tie-2/Tek and CD105 expression in breast cancer (n=905)
por: Dales, J P, et al.
Publicado: (2004)

Evaluation of MAGE-1 and MAGE-3 as tumour-specific markers to detect blood dissemination of hepatocellular carcinoma cells
por: Mou, D-C, et al.
Publicado: (2002)

Cooperation between monocytes and breast cancer cells promotes factors involved in cancer aggressiveness
por: Blot, E, et al.
Publicado: (2003)

Both gene expression for orotate phosphoribosyltransferase and its ratio to dihydropyrimidine dehydrogenase influence outcome following fluoropyrimidine-based chemotherapy for metastatic colorectal cancer
por: Ichikawa, W, et al.
Publicado: (2003)

Quantitation of circulating DNA in the serum of breast cancer patients by real-time PCR
por: Gal, S, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_untmk2r642ioc01mvmvaf5u7i8